Global Critical Illness Insurance Market
Market Size in USD Billion
CAGR :
%
USD
216.50 Billion
USD
369.97 Billion
2022
2030
| 2023 –2030 | |
| USD 216.50 Billion | |
| USD 369.97 Billion | |
|
|
|
|
Global Critical Illness Insurance Market, By Product Type (Disease Insurance, Medical Insurance, and Income Protection Insurance), Application (Cancer, Heart Attack, and Stroke) – Industry Trends and Forecast to 2030
Critical Illness Insurance Market Analysis and Size
The critical illness insurance market is expected to witness lucrative growth. An increase in the number of critical illness cases such as stroke, cancer, renal failure, and heart attack has proved to be the main cause of awareness among people. The increasing cases of critical illness and more expenditure for the insurer and uninsured population are expected to drive the growth of the critical illness insurance market. Rising medical expenses are expected to drive the critical illness insurance market.
Data Bridge Market Research analyses that the critical illness insurance market, which was USD 216.5 Billion in 2022, would rocket up to USD 369.97 Billion by 2030 and is expected to undergo a CAGR of 10.40% during the forecast period. “Medical Insurance” dominates the product segment of the critical illness insurance market owing to the increasing awareness and understanding of critical illnesses. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Critical Illness Insurance Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product Type (Disease Insurance, Medical Insurance, and Income Protection Insurance), Application (Cancer, Heart Attack, and Stroke), |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) |
|
Market Players Covered |
AEGON Life Insurance Company Ltd( Netherlands), AXA Hong Kong(Hong Kong), Legal & General Group plc(U.K.), Generali China Life Insurance Co. Ltd.(China), Prudential Hong Kong Limited(Hong Kong), Bajaj Allianz General Insurance Co. Ltd.(India), Tata AIG General Insurance Company Limited(India), United Healthcare Services Inc.(U.S.), Zurich American Insurance Company(U.S.) , AmMetLife Insurance Berhad (Malaysia), Star Union Dai-ichi Life Insurance Company Limited(India) , Sun Life Assurance Company of Canada.(Canada) , AFLAC INCORPORATED(U.S.) , Liberty General Insurance Ltd.(India) , HCF(Australia) , Star Union Dai-ichi Life Insurance Company Limited.(India) , Future Generali India Insurance Company Ltd.(India) , Religare Health Insurance Company Limited(India), Cigna(U.S.). Manulife Financial Corporation (Canada), Prudential Financial, Inc. (United States) |
|
Market Opportunities |
|
Market Definition
Critical illness is mainly associated with any illness, disease, or health condition which is a potential or immediate threat to life and needs comprehensive care and continuous monitoring, often in intensive care. Critical illness insurance is an insurance product which helps to check if an insurer is contracted to typically make payments if the policyholder is diagnosed with any kind of specific illnesses on a predetermined list as part of an insurance policy.
Global Critical Illness Insurance Market Dynamics
Drivers
- Increasing prevalence of critical illnesses
The rising incidence of critical illnesses such as cancer, heart disease, and stroke is a significant driver for the critical illness insurance market. As individuals become more aware of the financial burden associated with these illnesses, the demand for insurance coverage to mitigate the costs of treatment and recovery increases.
- Growing healthcare expenditure
The escalating costs of medical treatments and healthcare services have fuelled the demand for critical illness insurance. Individuals seek coverage that can provide financial support for expensive medical procedures, hospitalizations, medications, and post-treatment care.
- Advancements in medical technology and improved survival rates
Advances in medical technology and treatment protocols have led to improved survival rates for critical illnesses. As more individuals survive critical illnesses, the need for financial protection and support during recovery becomes crucial, driving the demand for critical illness insurance.
Opportunities
- Untapped markets and emerging economies
There are significant growth opportunities in untapped markets and emerging economies, where awareness and adoption of critical illness insurance are relatively low. As these markets evolve and healthcare awareness increases, the demand for insurance coverage against critical illnesses is expected to rise.
- Product innovation and customization:
Insurers have the opportunity to develop innovative and customized critical illness insurance products. By offering flexible coverage options, tailored packages, and additional benefits, insurers can cater to the diverse needs and preferences of individuals seeking critical illness coverage.
Restraints/ Challenges
- Affordability and accessibility
The affordability and accessibility of critical illness insurance can be a significant restraint. Premium costs may be prohibitive for some individuals, particularly in low-income segments of the population. Additionally, insurance coverage may be limited or unavailable for individuals with pre-existing conditions or higher risk profiles.
- Lack of awareness and understanding
A lack of awareness and understanding about critical illness insurance among the general population can hinder market growth. Many individuals may not fully comprehend the benefits and coverage provided by such policies, leading to lower demand and adoption.
- Complex underwriting and risk assessment
Critical illness insurance involves complex underwriting and risk assessment processes. Evaluating an individual's risk profile and determining appropriate coverage can be challenging, particularly for conditions with varying degrees of severity and prognosis.
- Regulatory and compliance issues
The critical illness insurance market is subject to regulatory frameworks and compliance requirements that vary across different regions. Insurers must navigate these regulations and ensure compliance, which can present challenges and increase operational complexities.
This critical illness insurance market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the critical illness insurance market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In July 2020, Liberty General Insurance launched ‘Critical Connect’, where one can choose from two programs for a sum insured ranging from Rs 1 lakh up to Rs. 1 crore. If the customer opts for plan A, he or she can choose Critical Illness Bundles Covering 9, 25, or 43 critical illnesses. Whereas, plan B offers disease-specific bundles such as Heart Protect, Cancer Protect, Renoliv Protect, and Brain Protect. With this launch, the company has enhanced its offering to customers for critical illness insurance.
- In November 2022, Nassau Financial Group announced that it entered into a binding agreement with Delaware Life Insurance Company to buy the Delaware Life Insurance Company of New York.
Global Critical Illness Insurance Market Scope
Critical illness insurance market is segmented on the basis of product type and application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
Product Type
- Disease insurance
- Medical insurance
- Income protection insurance.
Application
- Cancer
- Heart attack
- Stroke.
Critical Illness Insurance Market Regional Analysis/Insights
The critical illness insurance market is analyzed, and market size insights and trends are provided by country, power source, product, and application, as referenced above.
The countries covered in the critical illness insurance market report are the U.S., Canada, and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is likely to lead the global critical illness insurance market. The rising cases of chronic diseases such as cancer and the increase in medical expenses in the region have driven the regional market. However, the sudden boom in cancer diagnosis and the increasing rate of death is the main factor propelling the growth of the regional market.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to rise in the demand for health insurance policies in densely populated countries such as India and China.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Critical illness insurance market also provides you with a detailed market analysis for every country’s growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the critical illness insurance market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the critical illness insurance market. The data is available for the historic period 2015-2020.
Competitive Landscape and Critical Illness Insurance Market Share Analysis
The critical illness insurance market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the critical illness insurance market.
Some of the major players operating in the critical illness insurance market are:
- AEGON Life Insurance Company Ltd. - Netherlands
- AXA Hong Kong - Hong Kong
- Legal & General Group plc - United Kingdom
- Generali China Life Insurance Co. Ltd. - China
- Prudential Hong Kong Limited - Hong Kong
- Bajaj Allianz General Insurance Co. Ltd. - India
- Tata AIG General Insurance Company Limited - India
- United Healthcare Services Inc. - United States
- Zurich American Insurance Company - United States
- AmMetLife Insurance Berhad - Malaysia
- Star Union Dai-ichi Life Insurance Company Limited - India
- Sun Life Assurance Company of Canada - Canada
- AFLAC INCORPORATED - United States
- Liberty General Insurance Ltd. - India
- HCF - Australia
- Future Generali India Insurance Company Ltd. - India
- Religare Health Insurance Company Limited - India
- Cigna - United States
- Manulife Financial Corporation - Canada
- Prudential Financial, Inc. - United States
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CRITICAL ILLNESS INSURANCE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE KINESIO TAPE SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES VOLUME DATA
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CRITICAL ILLNESS INSURANCE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 MERGERS AND ACQUISITIONS
10.8 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
FIGURE 1 TOP ENTITIES BASED ON R&D GLANCE FOR GLOBAL CRITICAL ILLNESS INSURANCE MARKET
Sources: Press Releases, Annual Reports, SEC Filings, Investor Presentations, Other Government Sources, Analysis Based on Inputs from Secondary, Expert Interviews
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY TYPE OF INSURANCE
16.1 OVERVIEW
16.2 INDIVIDUAL CRITICAL ILLNESS INSURANCE
16.3 GROUP CRITICAL ILLNESS INSURANCE
16.4 FAMILY FLOATER CRITICAL ILLNESS INSURANCE
16.5 STANDALONE CRITICAL ILLNESS INSURANCE
16.6 RIDER (ADD-ON) CRITICAL ILLNESS INSURANCE
17 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY DISEASE
17.1 OVERVIEW
17.2 CANCER
17.2.1 BREAST CANCER
17.2.2 LUNG CANCER
17.2.3 COLORECTAL CANCER
17.2.4 PROSTATE CANCER
17.2.5 OTHERS
17.3 CARDIOVASCULAR DISEASES
17.3.1 MYOCARDIAL INFARCTION (HEART ATTACK)
17.3.2 STROKE
17.3.3 CORONARY ARTERY BYPASS SURGERY
17.3.4 ANGIOPLASTY
17.3.5 OTHERS
17.4 NEUROLOGICAL DISORDERS
17.4.1 MULTIPLE SCLEROSIS
17.4.2 PARKINSON'S DISEASE
17.4.3 ALZHEIMER'S DISEASE
17.4.4 MOTOR NEURON DISEASE
17.4.5 OTHERS
17.5 ORGAN TRANSPLANTS
17.5.1 KIDNEY TRANSPLANT
17.5.2 LIVER TRANSPLANT
17.5.3 HEART TRANSPLANT
17.5.4 LUNG TRANSPLANT
17.5.5 OTHERS
17.6 OTHERS
18 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY AGE GROUP
18.1 OVERVIEW
18.2 CHILDREN (BELOW 18 YEARS)
18.3 YOUNG ADULTS (18-35 YEARS)
18.4 MIDDLE-AGED ADULTS (36-55 YEARS)
18.5 SENIOR CITIZENS (ABOVE 55 YEARS)
19 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY POLICY TERM
19.1 OVERVIEW
19.2 STANDARD SHORT-TERM POLICIES (LESS THAN 5 YEARS)
19.3 MEDIUM-TERM POLICIES (5-10 YEARS)
19.4 LONG-TERM POLICIES (MORE THAN 10 YEARS)
20 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY PREMIUM TYPE
20.1 OVERVIEW
20.2 REGULAR PREMIUM
20.3 SINGLE PREMIUM
20.4 LIMITED PREMIUM
21 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY END USER
21.1 OVERVIEW
21.2 INDIVIDUALS
21.3 CORPORATE EMPLOYEES
21.4 SELF-EMPLOYED INDIVIDUALS
21.5 FAMILIES
22 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY DISTRIBUTION CHANNEL
22.1 OVERVIEW
22.2 DIRECT SALES
22.3 INSURANCE BROKERS/AGENTS
22.4 BANKS (BANCASSURANCE)
22.5 ONLINE PLATFORMS
22.6 CORPORATE SALES
23 GLOBAL CRITICAL ILLNESS INSURANCE MARKET BY COVERAGE AMOUNT
23.1 OVERVIEW
23.2 UP TO USD 50,000
23.3 USD 50,001 - USD 100,000
23.4 USD 100,001 - USD 500,000
23.5 ABOVE USD 500,000
24 GLOBAL CRITICAL ILLNESS INSURANCE MARKET, BY GEOGRAPHY
GLOBAL CRITICAL ILLNESS INSURANCE MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
24.1 NORTH AMERICA
24.1.1 U.S.
24.1.2 CANADA
24.1.3 MEXICO
24.2 EUROPE
24.2.1 GERMANY
24.2.2 FRANCE
24.2.3 U.K.
24.2.4 ITALY
24.2.5 SPAIN
24.2.6 RUSSIA
24.2.7 TURKEY
24.2.8 BELGIUM
24.2.9 NETHERLANDS
24.2.10 SWITZERLAND
24.2.11 REST OF EUROPE
24.3 ASIA-PACIFIC
24.3.1 JAPAN
24.3.2 CHINA
24.3.3 SOUTH KOREA
24.3.4 INDIA
24.3.5 AUSTRALIA
24.3.6 SINGAPORE
24.3.7 THAILAND
24.3.8 MALAYSIA
24.3.9 INDONESIA
24.3.10 PHILIPPINES
24.3.11 REST OF ASIA-PACIFIC
24.4 SOUTH AMERICA
24.4.1 BRAZIL
24.4.2 ARGENTINA
24.4.3 PERU
24.4.4 CHILE
24.4.5 COLOMBIA
24.4.6 VENEZUELA
24.4.7 REST OF SOUTH AMERICA
24.5 MIDDLE EAST AND AFRICA
24.5.1 SOUTH AFRICA
24.5.2 SAUDI ARABIA
24.5.3 UAE
24.5.4 EGYPT
24.5.5 ISRAEL
24.5.6 REST OF MIDDLE EAST AND AFRICA
24.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
25 GLOBAL CRITICAL ILLNESS INSURANCE MARKET, COMPANY LANDSCAPE
25.1 COMPANY SHARE ANALYSIS: GLOBAL
25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
25.3 COMPANY SHARE ANALYSIS: EUROPE
25.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
25.5 MERGERS & ACQUISITIONS
25.6 NEW PRODUCT DEVELOPMENT & APPROVALS
25.7 EXPANSIONS
25.8 REGULATORY CHANGES
25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
26 GLOBAL CRITICAL ILLNESS INSURANCE MARKET, SWOT AND DBMR ANALYSIS
27 GLOBAL CRITICAL ILLNESS INSURANCE MARKET, COMPANY PROFILE
27.1 ALLIANZ
27.1.1 COMPANY OVERVIEW
27.1.2 REVENUE ANALYSIS
27.1.3 GEOGRAPHIC PRESENCE
27.1.4 PRODUCT PORTFOLIO
27.1.5 RECENT DEVELOPEMENTS
27.2 CHINA LIFE INSURANCE COMPANY
27.2.1 COMPANY OVERVIEW
27.2.2 REVENUE ANALYSIS
27.2.3 GEOGRAPHIC PRESENCE
27.2.4 PRODUCT PORTFOLIO
27.2.5 RECENT DEVELOPEMENTS
27.3 SPIDERTECH INC. AFLAC INCORPORATED
27.3.1 COMPANY OVERVIEW
27.3.2 REVENUE ANALYSIS
27.3.3 GEOGRAPHIC PRESENCE
27.3.4 PRODUCT PORTFOLIO
27.3.5 RECENT DEVELOPEMENTS
27.4 AEGON
27.4.1 COMPANY OVERVIEW
27.4.2 REVENUE ANALYSIS
27.4.3 GEOGRAPHIC PRESENCE
27.4.4 PRODUCT PORTFOLIO
27.4.5 RECENT DEVELOPEMENTS
27.5 AIG
27.5.1 COMPANY OVERVIEW
27.5.2 REVENUE ANALYSIS
27.5.3 GEOGRAPHIC PRESENCE
27.5.4 PRODUCT PORTFOLIO
27.5.5 RECENT DEVELOPEMENTS
27.6 AMERICAN FIDELITY
27.6.1 COMPANY OVERVIEW
27.6.2 REVENUE ANALYSIS
27.6.3 GEOGRAPHIC PRESENCE
27.6.4 PRODUCT PORTFOLIO
27.6.5 RECENT DEVELOPEMENTS
27.7 AVIVA
27.7.1 COMPANY OVERVIEW
27.7.2 REVENUE ANALYSIS
27.7.3 GEOGRAPHIC PRESENCE
27.7.4 PRODUCT PORTFOLIO
27.7.5 RECENT DEVELOPEMENTS
27.8 UNITEDHEALTHCARE
27.8.1 COMPANY OVERVIEW
27.8.2 REVENUE ANALYSIS
27.8.3 GEOGRAPHIC PRESENCE
27.8.4 PRODUCT PORTFOLIO
27.8.5 RECENT DEVELOPEMENTS
27.9 DESJARDINS GROUP
27.9.1 COMPANY OVERVIEW
27.9.2 REVENUE ANALYSIS
27.9.3 GEOGRAPHIC PRESENCE
27.9.4 PRODUCT PORTFOLIO
27.9.5 RECENT DEVELOPEMENTS
27.1 LEGAL & GENERAL GROUP PLC
27.10.1 COMPANY OVERVIEW
27.10.2 REVENUE ANALYSIS
27.10.3 GEOGRAPHIC PRESENCE
27.10.4 PRODUCT PORTFOLIO
27.10.5 RECENT DEVELOPEMENTS
27.11 GENERALI CHINA LIFE INSURANCE CO. LTD.
27.11.1 COMPANY OVERVIEW
27.11.2 REVENUE ANALYSIS
27.11.3 GEOGRAPHIC PRESENCE
27.11.4 PRODUCT PORTFOLIO
27.11.5 RECENT DEVELOPEMENTS
27.12 PRUDENTIAL HONG KONG LIMITED
27.12.1 COMPANY OVERVIEW
27.12.2 REVENUE ANALYSIS
27.12.3 GEOGRAPHIC PRESENCE
27.12.4 PRODUCT PORTFOLIO
27.12.5 RECENT DEVELOPEMENTS
27.13 AMMETLIFE INSURANCE BERHAD
27.13.1 COMPANY OVERVIEW
27.13.2 REVENUE ANALYSIS
27.13.3 GEOGRAPHIC PRESENCE
27.13.4 PRODUCT PORTFOLIO
27.13.5 RECENT DEVELOPEMENTS
27.14 STAR UNION DAI-ICHI LIFE INSURANCE COMPANY LIMITED
27.14.1 COMPANY OVERVIEW
27.14.2 REVENUE ANALYSIS
27.14.3 GEOGRAPHIC PRESENCE
27.14.4 PRODUCT PORTFOLIO
27.14.5 RECENT DEVELOPEMENTS
27.15 SUN LIFE ASSURANCE COMPANY OF CANADA
27.15.1 COMPANY OVERVIEW
27.15.2 REVENUE ANALYSIS
27.15.3 GEOGRAPHIC PRESENCE
27.15.4 PRODUCT PORTFOLIO
27.15.5 RECENT DEVELOPEMENTS
27.16 LIBERTY GENERAL INSURANCE LTD.
27.16.1 COMPANY OVERVIEW
27.16.2 REVENUE ANALYSIS
27.16.3 GEOGRAPHIC PRESENCE
27.16.4 PRODUCT PORTFOLIO
27.16.5 RECENT DEVELOPEMENTS
27.17 HCF
27.17.1 COMPANY OVERVIEW
27.17.2 REVENUE ANALYSIS
27.17.3 GEOGRAPHIC PRESENCE
27.17.4 PRODUCT PORTFOLIO
27.17.5 RECENT DEVELOPEMENTS
27.18 FUTURE GENERALI INDIA INSURANCE COMPANY LTD.
27.18.1 COMPANY OVERVIEW
27.18.2 REVENUE ANALYSIS
27.18.3 GEOGRAPHIC PRESENCE
27.18.4 PRODUCT PORTFOLIO
27.18.5 RECENT DEVELOPMENTS.
27.19 RELIGARE HEALTH INSURANCE COMPANY LIMITED
27.19.1 COMPANY OVERVIEW
27.19.2 REVENUE ANALYSIS
27.19.3 GEOGRAPHIC PRESENCE
27.19.4 PRODUCT PORTFOLIO
27.19.5 RECENT DEVELOPEMENTS
27.2 CIGNA
27.20.1 COMPANY OVERVIEW
27.20.2 REVENUE ANALYSIS
27.20.3 GEOGRAPHIC PRESENCE
27.20.4 PRODUCT PORTFOLIO
27.20.5 RECENT DEVELOPEMENTS
27.21 MANULIFE FINANCIAL CORPORATION -
27.21.1 COMPANY OVERVIEW
27.21.2 REVENUE ANALYSIS
27.21.3 GEOGRAPHIC PRESENCE
27.21.4 PRODUCT PORTFOLIO
27.21.5 RECENT DEVELOPEMENTS
27.22 PRUDENTIAL FINANCIAL, INC.
27.22.1 COMPANY OVERVIEW
27.22.2 REVENUE ANALYSIS
27.22.3 GEOGRAPHIC PRESENCE
27.22.4 PRODUCT PORTFOLIO
27.22.5 RECENT DEVELOPEMENTS
27.23 AXA HONG KONG
27.23.1 COMPANY OVERVIEW
27.23.2 REVENUE ANALYSIS
27.23.3 GEOGRAPHIC PRESENCE
27.23.4 PRODUCT PORTFOLIO
27.23.5 RECENT DEVELOPMENTS
27.24 ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED
27.24.1 COMPANY OVERVIEW
27.24.2 REVENUE ANALYSIS
27.24.3 GEOGRAPHIC PRESENCE
27.24.4 PRODUCT PORTFOLIO
27.24.5 RECENT DEVELOPEMENTS
27.25 GUARDIAN LIFE INSURANCE COMPANY OF AMERICA
27.25.1 COMPANY OVERVIEW
27.25.2 REVENUE ANALYSIS
27.25.3 GEOGRAPHIC PRESENCE
27.25.4 PRODUCT PORTFOLIO
27.25.5 RECENT DEVELOPMENTS
27.26 OLD MUTUAL LIMITED
27.26.1 COMPANY OVERVIEW
27.26.2 REVENUE ANALYSIS
27.26.3 GEOGRAPHIC PRESENCE
27.26.4 PRODUCT PORTFOLIO
27.26.5 RECENT DEVELOPEMENTS
28 CONCLUSION
29 QUESTIONNAIRE
30 ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

